Editor’s Note: This article is a reprint. It was originally published August 9, 2017. Human fertility is in a downward spiral, scientists warn and modern life — with its technological and chemical “progress” — is likely to blame. Female infertility tends to get the most attention, but in this case, it’s male infertility that has… Read More »
FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 7, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. The… Read More »
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Harvard-afilliated Massachusetts General Hospital (MGH)… Read More »
Researchers from 68 sites across the country, led by David E. Leaf and Shruti Gupta from the Division of Renal Medicine at Harvard-affiliated Brigham and Women’s Hospital, have investigated the effects of the anti-inflammatory drug tocilizumab on critically ill patients with laboratory-confirmed COVID-19. Unlike steroids, which suppress the immune system more broadly, tocilizumab specifically inhibits the receptor for… Read More »
New research suggests that a rat’s experiences may act as an early warning system to its fellow rodents. Share on PinterestNew research sheds light on the mechanism of empathy in rats. Empathy is the ability to understand someone else’s emotional experiences. Typically, we think of empathy as a noble quality that we relate to compassion.… Read More »
Progress on treating cancer has stalled in Scotland because of staff shortages and a lack of funding, according to a parliamentary report. The Scottish Parliament’s Cross-Party Group on Cancer found that 18% of cancer patients in June were not seen within the six-week target. Their report, which will be published later, has been described as… Read More »